T-cell monitoring and immunotherapy for treating graft-versus-host disease

Effie W Petersdorf

Genetic Mechanisms of Survivorship Disparities after Unrelated HCT

Leukaemia

Pier Paolo Pandolfi

Targeting Tumor Suppressive Pathways for Cancer Therapy

Leukaemia

Richard John O'Reilly

Immunobiology for Marrow Allografts for Leukemia

Leukaemia

Melinda Sue Butschkovacic

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection

Non-Hodgkin lymphoma Hodgkin lymphoma

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Wilburn E. Reddick

ALL therapy and developing brains: MRI measures, genetic factors and cognition

Leukaemia

Pediatric oncology or childhood cancer

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Christopher S Carlson

Impact of primary tumor development stage on prognosis and outcome in B-ALL

Leukaemia

Pediatric oncology or childhood cancer